NASDAQ
Aurinia Pharmaceuticals Inc. (AUPH) has a free cash flow growth of -26.92% as of Friday, May 29, 2026. This represents a 103.32% decrease compared to its 12-month average of 811.42%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.